A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

Douglas Jay Cohen net worth and biography

Douglas Cohen Biography and Net Worth

Director of Organovo

Douglas Jay Cohen has served as president and Chief Executive Officer of IR Medtek LLC since January 2019, a medical device company developing a non-invasive probe for cancer detection by primary care physicians using a technology licensed from the Ohio State University. Prior to IR Medtek, Mr. Cohen served as President and Chief Executive Officer of Beacon Street Innovations, an advanced technology printing company from September 2016 to present. From January 1994 to September 2016, Mr. Cohen served as Vice President of Operations and Engineering at Screen Machine Industries, an industrial and construction heavy equipment manufacturer. As an active investor in startup companies, Mr. Cohen has invested in over 20 biotech startups in the past 10 years, including investing in Organovo in 2013 and maintaining a position in the company ever since. Mr. Cohen received a B.S. from the Massachusetts Institute of Technology.

How do I contact Douglas Jay Cohen?: The corporate mailing address for Mr. Cohen and other Organovo executives is 440 STEVENS AVENUE SUITE 200, SOLANA BEACH CA, 92075. Organovo can also be reached via phone at (858) 224-1000 and via email at [email protected]. Learn More on Douglas Jay Cohen's contact information.
Has Douglas Jay Cohen been buying or selling shares of Organovo?: Douglas Jay Cohen has not been actively trading shares of Organovo in the last ninety days. Most recently, on Tuesday, August 17th, Douglas Jay Cohen bought 8,750 shares of Organovo stock. The stock was acquired at an average cost of $6.72 per share, with a total value of $58,800.00. Learn More on Douglas Jay Cohen's trading history.
Are insiders buying or selling shares of Organovo?: In the last twelve months, insiders at the medical research company sold shares 1 times. They sold a total of 19,607 shares worth more than $31,763.34. The most recent insider tranaction occured on November, 15th when Director David Gobel sold 19,607 shares worth more than $31,763.34. Insiders at Organovo own 5.0% of the company. Learn More about insider trades at Organovo.
Information on this page was last updated on 11/15/2023.

Douglas Jay Cohen Insider Trading History at Organovo

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/17/2021	Buy	8,750	$6.72	$58,800.00

Douglas Jay Cohen Buying and Selling Activity at Organovo

Organovo Company Overview

Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive 3D bioprinted human liver tissue with distinct hepatocellular and non-parenchymal cell compartments. The company was incorporated in 2007 and is headquartered in San Diego, California.

Today's Range

Now: $1.00

$1.00

$1.05

50 Day Range

MA: $1.04

$0.98

$1.35

2 Week Range

Now: $1.00

$0.89

$2.05

Volume

127,006 shs

Average Volume

839,254 shs

Market Capitalization

$10.04 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.91

SHOCKING Crypto Leak…

From Crypto 101 Media | Ad